Trials / Sponsors / Aravive, Inc.
Aravive, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | 2021-07-28 |
| Terminated | Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Platinum-resistant Ovarian Cancer | Phase 3 | 2021-04-22 |
| Terminated | Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Clear Cell Renal Cell Carcinoma | Phase 1 / Phase 2 | 2021-02-26 |
| Terminated | Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy IgA Nephropathy | Phase 2 | 2019-11-27 |
| Completed | Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer Ovarian Cancer | Phase 1 | 2018-12-06 |
| Completed | A Phase 1 AVB-S6-500 Safety and Tolerability Study Healthy Volunteer | Phase 1 | 2018-01-31 |